Study highlights the benefits and potential risks of ADHD medication, revealing that stimulants like amphetamines and methylphenidate reduce the risk of psychiatric hospitalization and improve long-term employment outcomes, though concerns about adverse effects such as increased heart rate and potential for triggering psychosis or mania remain.
All pharma companies in the first round of Medicare price negotiations agree to participate
All companies with drugs on CMS’ list for the first round of Medicare price negotiations under the Inflation Reduction Act have agreed to participate as